These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9918728)

  • 1. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.
    Signorini M; Paulesu E; Friston K; Perani D; Colleluori A; Lucignani G; Grassi F; Bettinardi V; Frackowiak RS; Fazio F
    Neuroimage; 1999 Jan; 9(1):63-80. PubMed ID: 9918728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury.
    Zhang J; Mitsis EM; Chu K; Newmark RE; Hazlett EA; Buchsbaum MS
    J Neurotrauma; 2010 Jan; 27(1):35-49. PubMed ID: 19715400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
    Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
    Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis.
    Gallivanone F; Della Rosa PA; Perani D; Gilardi MC; Castiglioni I;
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):115-132. PubMed ID: 25479418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping.
    Kang E; Lee DS; Kang H; Lee JS; Oh SH; Lee MC; Kim CS
    Neuroimage; 2004 Aug; 22(4):1543-53. PubMed ID: 15275911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical parametric mapping: assessment of application in children.
    Muzik O; Chugani DC; Juhász C; Shen C; Chugani HT
    Neuroimage; 2000 Nov; 12(5):538-49. PubMed ID: 11034861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease.
    Mega MS; Chen SS; Thompson PM; Woods RP; Karaca TJ; Tiwari A; Vinters HV; Small GW; Toga AW
    Neuroimage; 1997 Feb; 5(2):147-53. PubMed ID: 9345544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis.
    Van Der Gucht A; Verger A; Guedj E; Malandain G; Hossu G; Yagdigul Y; Roch V; Poussier S; Maillard L; Karcher G; Marie PY
    Ann Nucl Med; 2015 Dec; 29(10):921-8. PubMed ID: 26323854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study.
    Paulesu E; Perani D; Fazio F; Comi G; Pozzilli C; Martinelli V; Filippi M; Bettinardi V; Sirabian G; Passafiume D; Anzini A; Lenzi GL; Canal N; Fieschi C
    Neuroimage; 1996 Oct; 4(2):87-96. PubMed ID: 9345500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping.
    Petit-Taboué MC; Landeau B; Desson JF; Desgranges B; Baron JC
    Neuroimage; 1998 Apr; 7(3):176-84. PubMed ID: 9597659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
    Juh R; Pae CU; Lee CU; Yang D; Chung Y; Suh T; Choe B
    Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of statistical parametric mapping of (18) F-FDG-PET in frontal lobe epilepsy.
    Plotkin M; Amthauer H; Merschhemke M; Lüdemann L; Hartkop E; Ruf J; Gutberlet M; Bertram H; Meencke HJ; Felix R; Venz S
    Nuklearmedizin; 2003 Oct; 42(5):190-6. PubMed ID: 14571315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    Brugnolo A; De Carli F; Pagani M; Morbelli S; Jonsson C; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BNM; Ossenkoppele R; Didic M; Guedj E; Arnaldi D; Massa F; Grazzini M; Pardini M; Mecocci P; Dottorini ME; Bauckneht M; Sambuceti G; Nobili F
    J Alzheimers Dis; 2019; 68(1):383-394. PubMed ID: 30776000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
    Minoshima S; Koeppe RA; Frey KA; Ishihara M; Kuhl DE
    J Nucl Med; 1994 Jun; 35(6):949-54. PubMed ID: 8195881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
    Antonini A; Kazumata K; Feigin A; Mandel F; Dhawan V; Margouleff C; Eidelberg D
    Mov Disord; 1998 Mar; 13(2):268-74. PubMed ID: 9539340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.